Content navigation:Xiao Haizhong analyzes who is the leading stock of the new crown vaccine? Which ones have benefited? According to the current progress, when will the new crown vaccine be launched? China's new coronavirus vaccine is on the market? China's first new crown vaccine is on the market. What are the advantages and disadvantages of various vaccines? After the new crown vaccine is on the market in China, who is recommended to be vaccinated first? China's first new crown vaccine is on the market. What are the advantages and disadvantages of various vaccines?
Q1: Xiao Haizhong analyzes who is the leading stock of the new crown vaccine? Which ones have benefited?
There is still no very safe and effective vaccine. If a company can develop it first, then the stock market value will definitely skyrocket, and the new crown vaccine has already had some eyebrows, so investors also want to know the leading stocks of the new crown vaccine Who is it? At present, it seems that Tibet Pharmaceuticals (600211) is the leader. Are you satisfied with my answer? If you’re satisfied, please adopt it.
Q2: When will the new crown vaccine be launched according to the current progress?
According to the current progress. Many new crown vaccines have undergone phase 2 clinical trials. It should be soon before the final listing, and it should definitely be possible before the end of the year.
Q3: Is China’s new coronavirus vaccine available?
Yes, on December 31, the Joint Prevention and Control Mechanism of the State Council was released.
Sinopharm China Bio-New Crown Inactivated Vaccine has been approved by the State Food and Drug Administration for conditional listing . Existing data show that the protection rate is 79.34%, achieving the unity of safety, effectiveness, accessibility, and affordability, and meeting the requirements of the relevant standards of the World Health Organization and the National Food and Drug Administration.
In the future, the persistence and protective effect of vaccine immunity need to be continuously observed. This achievement has not come easily. The listing of Chinese vaccines has injected confidence in the global victory over the epidemic and also provided strong support for vaccines to become a global public product.
Serious adverse reactions of the vaccine The incidence is about two per million.
Zeng Yixin, deputy director of the National Health Commission and head of the vaccine development team of the Joint Prevention and Control Mechanism Research Group of the State Council, said that in order to protect high-risk groups, this year In June, in accordance with the "New Coronavirus Vaccine Emergency Use Plan" approved in accordance with laws and regulations, we adopted the principle of small-scale start, prudent and informed consent, and under the premise of adequate adverse reaction monitoring and emergency treatment preparations, we will deal with high-risk The crowd launched an emergency vaccination of the new crown vaccine.
By the end of November, a total of more than 1.5 million doses had been vaccinated, and about 60,000 of them went to work in high-risk areas abroad. There were no reports of serious infections. The safety of the vaccine has been fully proven and effective Sex has also been verified to a certain extent.
my country officially launched the vaccination work for key populations in my country on December 15. In the past two months, the cumulative vaccination of key populations across the country has exceeded 3 million doses. In the vaccination work, we have established a series of systems such as complete set of vaccination sites, strict training of vaccination personnel, screening of recipients, monitoring of adverse reactions, emergency treatment and expert consultation for serious adverse reactions to ensure vaccination Work is safe and smooth.
The 3 million this time, plus the previous 1.5 million, fully prove that our vaccine is safe.
Reference source: Xiaoxiang Morning News-Free for all! China's new coronavirus vaccine launches
Reference source: Beijing Daily Client-China's new coronavirus vaccine launches